It is suggested that the antiarrhythmic effects of chronic intensive exercise or β‐blocker treatment are, at least in part, attributed to regulations of miR‐1‐mediated PP2A activity and its downstream targets, hyperphosphorylated CaMKII‐RyR2, in MI. Here, RYR2 is linked to myocardial infarction.